Internal Medicine, Cardiovascular Disease · Lafayette, LA
NPI
1861682239
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
2730 Ambassador Caffery Pkwy
Lafayette, LA, 70506
Phone (337) 988-1582
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
24,125 services
Medicare patients, 2024
3,115
Average age 75
Drug cost, 2024
$3.0M
31,751 prescriptions
Company payments, 2025
$566
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wade B May was code G0422 (intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session), 4,522 times for 244 patients. In total Wade B May billed 24,125 services in 109 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-08-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0422 Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | Office | 4,522 | 244 | $100.61 | $455K |
| G0423 Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | Office | 3,917 | 221 | $100.85 | $395K |
| 93000 Electrocardiogram | Office | 2,124 | 1,630 | $9.92 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,002 | 1,293 | $12.23 | $24K |
| 99214 Office E&M - Established | Office | 1,375 | 885 | $89.84 | $124K |
| 99213 Office E&M - Established | Office | 1,158 | 1,023 | $61.50 | $71K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,129 | 283 | $3.79 | $4,284 |
| 93306 Echocardiography (TTE/TEE) | Office | 703 | 690 | $130.50 | $92K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 454 | 54 | $46.41 | $21K |
| 93010 Electrocardiogram | Facility | 438 | 393 | $5.82 | $2,548 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 382 | 376 | $128.99 | $49K |
| 99454 E&M - Miscellaneous | Office | 335 | 81 | $35.20 | $12K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 311 | 218 | $418.53 | $130K |
| 93798 Cardiac Rehabilitation | Office | 308 | 24 | $18.31 | $5,639 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 279 | 33 | $47.03 | $13K |
By year: 2022 $2.0M for 23,559 services; 2023 $1.9M for 21,803 services; 2024 $2.0M for 24,125 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80061 Clinical Chemistry | 214 | 192 | $13.12 | $2,808 |
| 80053 Clinical Chemistry | 198 | 176 | $10.35 | $2,049 |
| 80048 Clinical Chemistry | 125 | 108 | $8.29 | $1,036 |
| 82172 Clinical Chemistry | 64 | 59 | $9.97 | $638 |
| 85027 Blood Count | 24 | 23 | $6.34 | $152 |
| 83036 Blood Count | 19 | 19 | $9.52 | $181 |
| 84075 Clinical Chemistry | 16 | 15 | $5.08 | $81.28 |
| 84450 Clinical Chemistry | 16 | 15 | $5.08 | $81.28 |
| 84460 Clinical Chemistry | 16 | 15 | $5.19 | $83.04 |
Medicare prescription drug claims, 2024
In 2024, the drug Wade B May prescribed most often to Medicare patients was Rosuvastatin Calcium, with 2,531 prescriptions and refills. In total Wade B May wrote 31,751 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 2,531 | 5,353 | 573 | $28K |
| Atorvastatin Calcium Generic | 2,333 | 4,971 | 531 | $19K |
| Metoprolol Succinate Generic | 2,327 | 4,762 | 529 | $29K |
| Amlodipine Besylate Generic | 2,172 | 4,545 | 524 | $9,411 |
| Ezetimibe Generic | 1,887 | 3,767 | 412 | $31K |
| Carvedilol Generic | 1,533 | 3,060 | 349 | $11K |
| Eliquis Apixaban | 1,372 | 2,023 | 243 | $1.2M |
| Furosemide Generic | 1,200 | 2,275 | 286 | $3,858 |
| Clopidogrel Clopidogrel Bisulfate | 889 | 1,909 | 211 | $6,844 |
| Lisinopril Generic | 840 | 1,704 | 186 | $4,018 |
| Losartan Potassium Generic | 811 | 1,749 | 194 | $7,282 |
| Hydrochlorothiazide Generic | 805 | 1,668 | 192 | $2,669 |
| Pravastatin Sodium Generic | 741 | 1,685 | 180 | $9,959 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 602 | 1,272 | 132 | $6,022 |
| Metoprolol Tartrate Generic | 599 | 1,129 | 130 | $2,844 |
Brand drugs: 3,690 claims; generic drugs: 28,061 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wade B May $566 ($566 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novartis Pharmaceuticals Corporation with $234.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $234 |
| Kestra Medical Technology Services, Inc. | 1 | $57.51 |
| Amgen Inc. AMGN | 3 | $54.98 |
| Philips North America LLC PHG | 1 | $44.79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36.07 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $31.15 |
| Merck Sharp & Dohme LLC MRK | 2 | $30.96 |
| Cleerly, Inc. | 1 | $24.75 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $19.22 |
| Novo Nordisk Inc NVO | 1 | $17.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.